ARTICLE | Financial News
Iterum sets IPO range
May 18, 2018 7:13 PM UTC
Antibiotics company Iterum Therapeutics plc (Dublin, Ireland) amended its proposed IPO on NASDAQ on May 16 and now plans to sell 5.3 million shares at $14-$16. At the $15 midpoint, the company would raise $80 million and be valued at $197 million...